Seasonal influenza vaccine (A/New York/39/2012) effectiveness against influenza A virus of health care workers in a long term care facility attached with the hospital, Japan, 2014/15: A cohort study.

[1]  Erin Burns,et al.  Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine. , 2016, MMWR. Morbidity and mortality weekly report.

[2]  S. de Lusignan,et al.  Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season results. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[3]  T. Odagiri,et al.  Keys to Control Influenza Outbreaks in Long-Term Care Facilities , 2015 .

[4]  D. Skowronski,et al.  Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015 , 2015, PloS one.

[5]  Lynnette Brammer,et al.  Influenza Activity — United States, 2014–15 Season and Composition of the 2015–16 Influenza Vaccine , 2015, MMWR. Morbidity and mortality weekly report.

[6]  M. Tortajada-Girbés,et al.  Effectiveness of influenza vaccination programme in preventing hospital admissions, Valencia, 2014/15 early results. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  M. Loeb,et al.  Interim estimates of 2014/15 influenza vaccine effectiveness in preventing laboratory-confirmed influenza-related hospitalisation from the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network, January 2015. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[8]  J. Beauté,et al.  Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[9]  Madeleine J. Marsland,et al.  Review of the 2014-2015 influenza season in the northern hemisphere. , 2015, Releve epidemiologique hebdomadaire.

[10]  S. de Lusignan,et al.  Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  J. Castilla,et al.  Influenza outbreaks in nursing homes with high vaccination coverage in Navarre, Spain, 2011/12. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[12]  S. Mukhi,et al.  Association between Patient Age and Influenza A Subtype during Influenza Outbreaks , 2010, Infection Control & Hospital Epidemiology.

[13]  T. Uyeki,et al.  Influenza estacional en adultos y niños—Diagnóstico, tratamiento, quimioprofilaxis y control de brotes institucionales: Guías de práctica clínica de la Sociedad de Enfermedades Infecciosas de Estados Unidos de América , 2009, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

[14]  Stefan Gravenstein,et al.  Influenza estacional en adultos y niños—Diagnóstico, tratamiento, quimioprofilaxis y control de brotes institucionales: Guías de práctica clínica de la Sociedad de Enfermedades Infecciosas de Estados Unidos de América , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  H. Aizawa,et al.  Differences in clinical features between influenza A H1N1, A H3N2, and B in adult patients , 2003, Respirology.